Related Experiment Video
Updated: Jun 11, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Increasing evidence for gender differences in chronic obstructive pulmonary disease.
Jolanda van Haren-Willems1, Yvonne Heijdra
1Radboud University Nijmegen Medical Centre, Department of Pulmonary Diseases - 454, 6500 HB Nijmegen, The Netherlands. j.vanharen-willems@long.umcn.nl
Women'S Health (London, England)
|July 6, 2010
Summary
Chronic obstructive pulmonary disease (COPD) is rising in women due to increased smoking and susceptibility to pollutants. Women face worse quality of life and greater challenges quitting smoking, requiring tailored support for rehabilitation.
Area of Science:
- Pulmonology
- Public Health
- Gender Medicine
Background:
- Increasing prevalence of chronic obstructive pulmonary disease (COPD) in women.
- Observed differences in COPD management and treatment outcomes between sexes.
- Need to understand gender-specific factors influencing COPD.
Purpose of the Study:
- Investigate reasons for rising COPD prevalence in women.
- Examine differences in COPD natural history and management between men and women.
- Identify gender-specific challenges and needs in COPD care.
Main Methods:
- Review of epidemiological data on COPD prevalence.
- Analysis of factors contributing to COPD development in women.
- Comparative assessment of COPD management strategies and treatment efficacy in men and women.
Main Results:
- Increased tobacco use is the primary driver of higher COPD rates in women.
- Women exhibit greater susceptibility to environmental smoke and pollution.
- Women report worse health-related quality of life and nutritional status compared to men with similar COPD severity.
- Women experience higher nicotine dependence and greater difficulty quitting smoking, exacerbated by cohabiting with smokers.
Conclusions:
- Tailored smoking cessation support is crucial for women, considering partner influence.
- Pulmonary rehabilitation programs require enhanced emotional and social support components for female patients.
- Addressing gender-specific vulnerabilities is key to improving COPD outcomes in women.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...